期刊
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
卷 80, 期 2, 页码 298-305出版社
ELSEVIER
DOI: 10.1016/j.ejpb.2011.10.022
关键词
beta-Casein; Paclitaxel; Oral delivery; Chemotherapy; Drug targeting; Nanoparticles
资金
- Yehuda and Civana Kahani
We studied a potential drug delivery system comprising the hydrophobic anticancer drug paclitaxel entrapped within beta-casein (beta-CN) nanoparticles and its cytotoxicity to human gastric carcinoma cells. Paclitaxel was entrapped by stirring its dimethyl sulfoxide (DMSO) solution into PBS containing beta-CN. Cryo-TEM analysis revealed drug nanocrystals, the growth of which was blocked by beta-CN. Entrapment efficiency was nearly 100%, and the nanovehicles formed were colloidally stable. Following encapsulation and simulated digestion with pepsin (2 hours at pH = 2, 37 degrees C), paclitaxel retained its cytotoxic activity to human N-87 gastric cancer cells; the IC50 value (32.5 +/- 6.2 nM) was similar to that of non-encapsulated paclitaxel (25.4 +/- 2.6 nM). Without prior simulated gastric digestion, beta-CN-paclitaxel nanoparticles were non-cytotoxic, suggesting the lack of untoward toxicity to bucal and esophageal epithelia. We conclude that beta-CN shows promise to be useful for target-activated oral delivery of hydrophobic chemotherapeutics in the treatment of gastric carcinoma, one of the leading causes of cancer mortality worldwide. (C) 2011 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据